Archived pages

Synergus RWE has contributed to this important study to demonstrate the value of FreeStyle Libre, utilising the rich data from Swedish diabetes registry linked with several other data-sources. These two abstracts are a…

We are happy to share the recent results from the NUB-applications submitted by our partner Dr Martin Braun. The results from this year are: 14 NUB applications for medical products/procedures: Status 1: 9 Out of these,…

Access denied. Go to front page

Page not found. Go to front page

Synergus RWE provide services in Western Europe: Strategy and execution of market access processes for diagnostics, digital solutions and medical devices. Strategy and execution of real-world evidence studies for any…

Here is a the result from our first AI based newsletter regarding rheumatoid arthritis. Click here if you want to register for the free newsletter. The list of publications below is created by our machine learning…

The French Organization for the Statutory Health Insurance (AMELI) has updated the CCAM procedure coding list based on news introduced in the version CCAM 47, which was approved on the 15th of June. Link to original…

The use of apps to collect patient reported data about quality of life, burden of disease and other variables are exploding. The Nordic countries gives a unique opportunity to combine the use of apps with rich real…

The submission period for applications to modify the Swiss DRG system at SwissDRG SA, the company responsible for development of the tariff system, is now open. Eligible national stakeholders, that is the Association of…

The download can be accessed from the Main Publications page on Delen. Additional discrepancies have been identified in the ICD-10 5th Edition books and have been added to Ref 115: NHS ICD-10 5th Edition Errata. The…

The Catalan Agency of Healthcare Quality and Evaluation of Healthcare Technologies (AQUAS) has updated the report on proton therapy for treatment of cancer. The update aimed at reviewing the new scientific evidence…

The Catalan Health Quality and Assessment Agency (AQUAS) has conducted a systematic review and meta-analysis of existing evidence on efficacy, safety and cost-effectiveness of bariatric surgery in obese patients…

Synergus database of health technology assessments for medical devices and IVDs ( HTA Update Search ) was for the first time recognized in the in-depth systematic review of HTA and market access for medical devices by…

The Swiss Federal Office for Public Health (BAG/OFSP) has announced the upcoming creation of a Unified Federal Registry for Cancers in the country. The new Registry will allow tracking, reporting and analysis of federal…

On October 27, 2017, the Sejm (the lower house of the Polish parliament) adopted the Basic Health Care Act. This is one of the groundbreaking changes that will be felt by patients and which was requested by many over…

Understanding the changes in European Market Access for Medical devices – Reviewing the history of TAVI and comparing what it would look like today? There has been quite a significant change in the European Market…

There is a large unmet need across many diseases requiring big data which single-country or even international registries lack the sample size and power to address. However, combining data from multiple registry sources…

Cancer Research UK commissioned research to understand the pressures facing pathology services across the UK and to identify solutions to address these issues. The work, conducted by 2020 Delivery, involved interviews…

Check the following options to unsubscribe to our mailing lists for the relevant

Please go to:

'.file_get_contents('http://eepurl.com/dJ7hcw').' '; ?> To view our privacy policy click

Health economic analysis is becoming more and more common part of reimbursement/health technology assessment review process. In addition to formal reimbursement/HTA requirements, economics for medical technology is…

Our services cover the following European Countries : Austria Belgium * Denmark Finland France * Germany * Italy Netherlands * Norway Spain Sweden Switzerland United Kingdom * For the countries marked with * we have one…

France has a well-developed system to provide solutions for Coverage with Evidence (CED)/Managed introduction. The first solution which has been set up in 2010 with the Article 165.1.1 is the “Forfait Innovation”, which…

With the increasing evidence requirements from decision makers, it is essential to evaluate the different opportunities that exist to get reimbursement during the evidence development and government-sponsored clinical…

In this Webinar, we will explore how the French system for "Coverage with Evidence Development" programs and Innovation Pathways, and how they provide early access to innovative medical devices even when pivotal data is…

Clinical Practice Research Datalink (CPRD) is the preeminent EHR database in the UK, providing de-identified patient data for over 30 years. This webinar aims to give an overview of the CPRD database and research…

In this webinar we have the honour of having Dr Morten Schmidt provide an overview of the Danish RWD landscape and the feasibility to utilize this data for outcomes research. He has several publications describing the…

Data that makes the difference The use of real-world data (RWD) to inform decisions by regulators and payers is increasing significantly. Many attempts to use RWD fail due to the lack of a structured search and…

The Swiss Federal Office of Statistics (BFS) and the SwissDRG SA organization have recently announced dates and deadlines related to the submission and collection of demands for medication of the procedure coding (CHOP)…

This is the first webinar in a series that we will provide about the methodological framework we use to develop RWE strategies. The focus is on RWE studies with the objective to demonstrate the real world effectiveness…

Diagnostic Market Access Diagnostic solutions are quite different from a market access perspective since most countries do not have any formal pathway to establish reimbursement. We can help you navigate this maze to…

Finnish Digital Health Finland has pioneered the use of HTA for Digital Health and developed a dedicated process named Digi-HTA for such solutions. The Digi-HTA process supports assessments activities for all kind of…

Digital Health Market Access - Germany The new legislation for digital health reimbursement in Germany, currently under implementation, provides the largest single opportunity for digital solutions globally. If you are…

There are many changes happening in France regarding Digital Health. For more information about each topic, click on the topic to see the corresponding blog post: PECA: The new pathway to conditional reimbursement…

Digital health Market Access Throughout the years we have developed a comprehensive knowledge of market access for different types of devices and diagnostics in different care settings from home care to specialized care…

There are many changes happening in France regarding Digital Health. For more information about each topic, click on the topic to see the corresponding blog post: PECA: The new pathway to conditional reimbursement…

Germany is a pioneer in establishing a national reimbursement system for digital solutions focused on patients through the DiGA and DIPA process. In this webinar, the following topics will be covered: European overview…

In this talk, Vincent Keunen will share the challenges he and his family e ncountered while going through a challenging health crisis: his own cancer, and the cancer of his 10 years old son. He will explain what he…

As part of our COVID-19 Horizon Collaboration Can a ‘simple app’ with data-privacy controls become a significant measure to manage the pandemic? According to the Pepp-PT organization more than 40 countries are…

The German Institute for Medical Documentation and Information (DIMDI) published the final ICD-10-GM 2018 classification for German diagnosis codes. The 2018 version consists of 56 changes resulting from the open…

The German Institute for Medical Documentation and Information (DIMDI) published the preliminary OPS 2018 classification for German procedure codes. The 2018 version consists of changes resulting from the procedures for…

The Dutch Health Authority (NZa) has made available the DBC (DRG) package version for 2018 in a circular that also explains the major regulatory changes, product structure and rates. This version will be enforced…

Collection of economic outcomes in the clinical trials are becoming more and more popular. Reporting of economic outcomes in the study is called “within-trial economic evaluation” and it has very high evidence level due…

Synergus’ analysis included the 10 latest HTA reports by different national and regional HTA bodies in Sweden. The reports covered various disease areas and technology areas, most of them related to treatment and…

Since the § 137e law was introduced five years ago, 33 methods have been assessed within the framework with more than 50% of them showing at least the potential to become a required treatment alternative. In a few…

Reference Healthcare Centers, Services and Units, or CSUR (Centros, Servicios y Unidades de Referencia ), are centers which perform specialized medical procedures or provide specialized treatments. Treatment received in…

Value-based healthcare (VBHC) measures the value of care as health outcome for the patient divided by the cost of care. Due to financial pressures, VBHC is being increasingly recognized as a potential way to reimburse…

Costs in healthcare are growing due to an increasing older population, chronic diseases and an expanding medical innovation market. Governments struggle to cover healthcare expenses and are looking for new ways to…

Value-based healthcare (VBHC) defines the value of care as the relation between the health outcome for the patient and the cost of care. By focusing on health outcomes rather than volumes, VBHC could help healthcare…

Value-based healthcare (VBHC) is not a new concept in many healthcare systems but is becoming increasingly more important due to financial pressures, advanced care, greater patient expectations, and ongoing economic…

Currently open positions: No open positions. Search Firm Representatives: We are not seeking assistance or accepting unsolicited resumes from search firms for opened employment

NHS England and NHS Improvement published 2017/18 and 2018/19 National Tariff Payment System 22nd of December 2016. National Tariff is used for reimbursement of majority of hospital and out-patient specialist services…

HTA (Health Technology Assessment) has long been used to evaluate certain medical devices and diagnostics. Now, a new EU HTA regulation is on the horizon, and it’s poised to bring major changes for the products it…

This webinar is hosted by Athagoras medtech HTA (Health Technology Assessment) has long been used to evaluate certain medical devices and diagnostics. Now, a new EU HTA regulation is on the horizon, and it’s poised to bring…

The European Commission has put forward a proposal to increase cooperation amongst Member States for health technology assessment (HTA). The aim of this potential directive is to enable greater transparency, empower…

Digital Health Market Access - European Review and Strategy The first question you have to address as a company is to determine which country has the most favorable situation to pay / reimbursement for your solution.…

The European Union (EU) Parliament has endorsed the new Regulation on In vitro Diagnostic Medical Devices (IVDR) and the new Regulation on Medical Devices (MDR). The official transition date will be around the 1st of…

Click here to learn more about our HTA update

Evidence For Decisions The foundation for our services is to support our clients in the development of evidence that will be used for decision making. We are at the fore front of understanding how Real-World Evidence…

Digital Health Market Access - Evidence Requirements and Outcomes If you are new to the topic of market access, it is important to become familiar with how medical interventions / drugs are typically evaluated prior to…

Digital Health Market Acccess - Evidence Strategy and Development The process to develop the required evidence to establish reimbursement for the digital solutions is one of the most critical issues for the success of a…

Job description and objectives: The main responsibility is to develop systematic literature reviews, reimbursement/HTA submission dossiers and value dossier for medical devices and diagnostics Project management in the…

With the temporary ‘ETAP’ solution, France has provided a pathway to establish national reimbursement for digital solutions in specific indications. In addition, it has been possible to apply for ‘brand-specific’…

This webinar summarises and charts the increasing reliance of clinical outcomes databases and disease registries in supporting HTA decision-making. It will cover the types of data used, why it is used, it’s application…

Using the large clinician owned and operated MSBase international registry of multiple sclerosis outcomes, this seminar will provide worked examples of how to apply and evaluate propensity score matching as a means of…

During its meeting of the 2nd of March, the Swiss Federal Council has decided to open a consultation procedure to review the Act on Therapeutic Products, which concerns the regulation for marketing and surveillance for…

In a note of November 23rd, the Federal Government has announced that the validity of the current version of TARMED, the tariff system for out-patient care, would be prolonged until the end of 2017. The current tariff…

SwissDRG SA, the organization in charge for maintenance and update of the Swiss DRG system, has released the final tariff version of the SwissDRG 7.0 system, valid for classification and reimbursement of acute care…

Head office Email: info@synergusrwe.com Address: Stationsvägen 18, 184 50 ÅKERSBERGA Click here to come to the contact us

Germany introduced a new legislation in 2016 that requires an assessment of the potential benefit of new methods based on high-risk medical devices before they can receive innovation funding (NUB). Results granting NUB…

More and more patients are getting new heart valves without open surgery. The number of new treatments for heart valve surgery has increased by four times in the last five years, according to the Norwegian Public Hearth…

Webinar E-health is a hot topic anticipated to transform healthcare. The mechanisms to fund and pay for e-health solutions are in many countries not as developed as the traditional pathways for drugs, medical devices…

The Federal Joint Committee (G-BA) made significant changes to the 2nd chapter and its appendix of its rules of procedure. The process of determining the appropriate overhead costs for § 137e study trials and the…

After a hospital submitted documents on the 6th of March, the Federal Joint Committee (G-BA) evaluated whether the method “external stabilization in arteriovenous anastomosis using a scaffold when implementing…

The Institute for Quality and Cost Effectiveness in the Health Care Sector (IQWIG) evaluated that PET/CT is suitable in some cases to avoid invasive neck dissections or laryngoscopic biopsies in patients with progressed…

Following a § 137e (7) application by the manufacturer, the Federal Joint Committee (G-BA) decided that the benefit of transcutaneous vagus nerve stimulation in drug-resistant epilepsy cannot be considered proven, yet.…

Hospitals applying for first-time innovation funding (NUB) for a high-risk medical (class IIb, III or active implants) devices in Germany have to undergo an elaborate evaluation procedure by the Federal Joint Committee…

The Federal Joint Committee (G-BA) has decided to stop the § 135 assessments of contact laser ablation (CLAP), visual laser ablation (VLAP), and transurethral microwave thermotherapy (TUMT) in benign prostate syndrome…

In this webinar we will give an introduction to the innovation funding for interventions in the German Hospital care and the link the government sponsored clinical trial. Historically Germany has been a market with easy…

Many medical device companies are aware about the German innovation funding (NUB) for hospital-based procedures. Historically it has proven to be an attractive pathway to establish early reimbursement. A few years ago,…

Many medical device companies are aware about the German innovation funding (NUB) for hospital-based procedures. Historically it has proven to be an attractive pathway to establish early reimbursement. A few years ago,…

In this webinar we will provide an introduction to the NUB funding and overview of how the new benefit assessment will provide impact on the innovation funding process. The new benefit assessment by G-BA and IQWiG will…

The German Institute for Medical Documentation and Information (DIMDI) has released all suggestions for German procedure (OPS) and diagnosis (ICD-10-GM) classification changes for 2018. Both classifications are used to…

The National Government has announced that it will present the new National Plan for Personalized Medicine 2019-2024 during the next Interterritorial Council of the National Health System (SNS) in April. The new Plan…

Medical Device - Hands-on market access support In addition to strategic market access consulting our team can provide hands-on support in selective geographies. Hands-on support may include: Development of application…

The French National Health Authority (HAS) has recently published a document which defines a roadmap for identification of the specificities of appraisal and evaluation of connected medical devices (CMDs). The clinical…

We provide full range of support in the area of health economics, including health economics modelling and incorporation of economic outcomes into clinical trials. Economic models can be published or presented in a…

Job description and objectives: Design decision-analytic health economic models Develop protocols, provide support and perform analysis for within-trial economic evaluations Development economic sections of value…

Authors from the National Authority for Health (HAS) published a review on the selection and methods used for deriving health state utility (HSU) estimates included in the cost-utility analyses (CUA) submitted by…

Health Economics We provide full range of support in the area of health economics, including health economics modelling and incorporation of economic outcomes into clinical trials. Economic models can be published or…

In this view you can search for your technology. Once you have navigated in the hierarchy to the technology you are looking for, right click on the bar and click on go to details. You will then find a summary of all the…

Synergus RWE is part of the Athagoras group, with complementing business units. Medtech Synergy RWE supports clients in developing pan-European strategies for market access and the need for evidence. The existing companies…

Following the budget conclave of July 2017, the Belgian Government has decided to implement cost control measures in the sector of implants and invasive medical devices, for savings accounting to 8 million EUR for the…

INAMI has issued a new list of reimbursement tariffs for implants and invasive medical aids effective from the 1st of March 2017. This applies specifically to the following products/treatment areas: Implants allowing…

The Belgian National Institute for Health and Disability (INAMI) has issued new Nomenclature of reimbursable procedures and services on the 8th of May, 2017. Modifications will enter force on June the 1st and apply…

On the 14th of June 2017, the Belgian National Institute for Health and Disability Insurance (INAMI) released the updated version of the two lists existing for reimbursement of medical devices in Belgium, including the…

The Belgian National Health and Disability Insurance (INAMI) issued new versions of the List of Reimbursable Devices and of corresponding Nominative Lists. The List of Reimbursable Devices identifies codes, generic…

The Belgian National Institute for Health Insurance and Disability (INAMI) has recently released the newest versions of Lists relevant for identification and reimbursement of medical devices. The new List of Materials…

The German DRG Institute (InEK) started the application process for NUB innovation funding for new methods. InEK is commissioned to assess whether new methods can be appropriately reimbursed through the DRG system and…

The Institute for the Hospital Remuneration System (InEK), being responsible for the development of the G-DRG system, finished the evaluation of the requests for innovation funding (NUB), which were sent in until 31st…

This seminar is originally designed to help Synergus RWE in how we can better operate as a multi-cultural organisation of employees, as well as to better work with clients from around the world. The seminar will give an…

Synergus is Med Tech consulting company with focus on market access, reimbursement and health economics for medical devices in European countries. Places are available for internship for students of Bioentrepreneurship,…

We are a growing company and are continuously looking offering opportunities for internships and thesis work for talented individuals. We do not provide payment during internships. We are currently offering internship…

In this webinar, Michel Verhasselt will share an overview of how the French healthcare system works in regards to market access. The seminar will also cover the different pathways that exist for medical devices,…

This webinar gives an introduction to how the German reimbursement system for in-patient hospital procedures operates. It will provide a brief description of the core-elements of the annual updating cycle and the…

With a Public Notice included in the Official Journal of the French Republic on December the 19th 2015, the French Ministry of Social Affairs, Health and Women’s Rights introduced new possibilities of reimbursement for…

The Institute for Quality and Cost Effectiveness in the Health Care Sector (IQWIG) published a major update of its method paper. The version 5.0 comes into force immediately and describes which scientific principles the…

The paper "Analysis of clinical trials of medical devices" was carried out in cooperation with the State Department of Health and Welfare (LAGeSo) and the office of the Ethics Committee of the State of Berlin (EK…

The Italian Court of Auditors approved the Decree of the Prime Minister on new Essential Levels of Service (LEAs) in the Italian health system. The new LEAs update the national positive list of healthcare basket…

On January the 13th, the Italian Prime Minister Paolo Gentiloni signed and approved the new List of Essential Levels of Care (so-called LEAs) developed by the Ministry of Health and the Regions in the last months. LEAs…

The Joint Action on Innovative Partnership for Action against Cancer (IPPAC) has been selected for funding under the 2017 Work Plan of the Health Programme. It includes 21 Member States, as well as Norway, Moldova and…

In the last few years, the Belgian Ministry of Health has been developing possible reforms to improve the effectiveness and efficiency of healthcare financing in the country, particularly with regards to financing of…

The Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) has evaluated the effect of light therapy and systemic drug treatment for moderate and severe psoriasis. The systemic drugs can…

The Nordic Casemix Center is a forum were DRG expert representatives from the Nordic countries can meet and discuss the NordDRG system. Several new cases regarding DRG chanes and grouping logic questions / issues are…

We are trying to help a group of highly skilled MDs who recently have fled to Sweden. Every week, we will promote specific profiles to highlight how they can be of help to you. Read more about the idea here.

We are trying to help a group of highly skilled MDs who recently have fled to Sweden. Every week, we will promote specific profiles to highlight how they can be of help to you. Read more about the idea here. The focus…

We are trying to help a group of highly skilled MDs who recently have fled to Sweden. Every week, we will promote specific profiles to highlight how they can be of help to you. Read more about the idea

We provide a full range of services to path the way for your technology in European countries. Digital Health Market Access in Digital Health is an evolving field, where there are only a few national solutions…

Job description and objectives: Leading market access consulting projects in the United Kingdom and other European countries Development of reimbursement analysis for medical devices and in-vitro diagnostics Development…

Don't miss this exciting event about Market Access for Digital Health Solutions arranged by COCIR. Moderator: Dr. Charles Alessi, Editohealth 14:00 – 14:05 Welcome and Introduction, by Annabel Seebohm, COCIR Secretary…

In this webinar we will have an opportunity to learn about the status of Market Access for Digital Health in Switzerland. Similar to other countries, there are theoretical ways to establish reimbursement through…

Stockholm, Sweden The role: Synergus AB, HEOR and market access consultancy, is seeking to find an experienced German-speaking analyst with specific interest, skills and knowledge from either strategic market access…

Stockholm, Sweden The role: Synergus AB, HEOR and market access consultancy, is seeking to find an experienced analyst with specific interest, skills and knowledge from either strategic market access consulting, data…

We are happy to announce an extension of our services to cover the Middle East. In our services in the middle east we can help you understand the dynamics of market access for your medical device / diagnostic in any of…

Overall, 471 news were reported, with about 30% coming from England (140 reports). Other countries with frequent updates of reimbursement system included Belgium (45 reports), Germany (37 reports), Russia (35 reports)…

Synergus maintains its knowledge about reimbursement systems in a form of country reports in MS Word. All country reports have standard structure and a specific process behind to keep report up-to-date. Typically,…

Medical Device - Market Access Strategy Unlike regulatory approval (CE-mark), there is no unified market access pathway in Europe. Every country has specific mechanism for reimbursement and funding of medical devices…

Medical Device Market Access Our business is to help you find the most optimal way to establish the desired market uptake in your countries of target. In this process we can provide services throughout the life cycle,…

Don't miss to stop by our booth at Ispor in Glasgow. We have booth 108. Chose a time here:

Copenhagen, Denmark We are exhibiting at Ispor 2019 in Copenhagen and would love to meet you there. Please use these links to book a meeting there: 15 min meeting 30 min meeting We will have booth C3-071. Looking…

mHealthBelgium: a joint initiative for digital health by industry and government You hear it so often: “digital is the future”, and this is also applicable to the health care domain. Apps are used on a daily basis, and…

Based on the experience of the hundreds of projects we have delivered, we have developed a new solution to provide a comprehensive overview of your reimbursement situation including information (optional) about the…

The focus on many medical device companies is on establishing reimbursement, which is mechanism of payment for technology. However, once mechanism is place the very critical element of funding by payers shall be…

The National Clinical Coding Standards ICD-10 and OPCS-4.8 reference books, for use from 1 April 2018, are now available to download from the Main Publications page on Delen. The Table of Changes section has been…

The new French version for diagnosis classification ICD-10 FR (or CIM-10) has been published in the French Official Journal. The classification includes codes and definitions for diagnoses that can be used to report…

A new convention will be started at the Belgian Institute for Health and Disability Insurance (INAMI) for the provision and reimbursement of biological tests through next generation sequencing (NGS) for personalized…

Data recently presented by the Italian Society of Urology (SIU) confirms that Italy is the leading European country for use of robotic surgery. In 2017, 18,000 procedures were performed using robotic surgery; two out of…

We are happy to announce that new member of Synergus team is Dr. Huseyin Aytug. Dr. Huseyin has B.A in Economics with distinction from Marmara University in Istanbul, Turkey, M.A (2010) and Ph.D. (2013) both in…

We are happy to announce that Günay Karli has joined our team. He is extending our current expertise in real world data. Prior to joining Synergus, he was an associated professor in computer science. His research has…

German Digital Reimbursement Act (DVG) - The most important opportunity for digital solutions (globally)? With the new legislation for national reimbursement of digital solutions, Germany has become the single largest…

Mattias Kyhlstedt will deliver a talk at the Nordic E-health conference, Vitalis .…

The new German Digital Reimbursement Act (DVG) – The most important opportunity for digital solutions (globally)? With the new legislation for national reimbursement of digital solutions, Germany has become the single…

Those involved in the system New Methods have formulated guiding criteria for the management of medical devices to be evaluated in this system. The document provides step-by-step guidance on which medical devices are…

On 1st of July, a new Pay for Performance (P4P) Program has been introduced in Belgium for reimbursement of activities of general hospitals. The Program is part of the reform of hospital financing. Hospitals will…

The new policy issued by NZa comprises information regarding funding and budget for specialized and hospital care. It includes availability fee for the following subjects: - specialized burn care - trauma care through…

We are starting a new project which aims to map and analyse new innovative tools in Heart Failure management. This project will also explore the methodological issues that should be considered by decision-makers in the…

With the increased utility of Real World Evidence, a critical question is the methodological issues of understanding how to transfer the results from a Real World Evidence study in one country to another country. In the…

A newly published article by Cheung et al. aimed to quantify and compare the relative importance of barriers and facilitators regarding the use of HTA in several European countries. A survey was conducted among 136…

The latest report on healthcare financing published by the Italian National Institute of Statistics (ISTAT) reveals that the impact of private expenditures in the country has drastically increased in the 4-year period…

A newly published study reviews the use of Real World Data (RWD) in health technology assesment (HTA). Reports published between the 1st of January 2011 and the 31st of December from 2016 from the National Institute for…

New tariffs for reimbursement of inpatient and outpatient care (MCO) as well as home care and home hospitalizations (HAD) have been approved and published in the Official Journal of the French Republic. Tariffs are…

The Swedish version of International Statistical Classification of Diseases and Related Health Issues (ICD-10) has been released and now available for downloading. The primary purpose of this ICD-10-SE version is to…

NHS England and Monitor has launched a public consultation on 2016/2017 NHS National Tariff Payment System until March 11 2016. In this consultation notice, feedback is sought on tariff proposals for 2016/17, including…

NICE Evidence Standards Framework for digital health and care technologies Digital health technologies offer the potential for user and system benefits, but many have low levels of evidence to support their…

This webinar will describe how the National Institute for Health Research (NIHR) works in partnership with medical device and diagnostics companies to help them successfully translate ideas into innovative medical…

In May 2015, the Norwegian Institute of Public Health was commissioned by the Ordering Forum of New Methods, to hold the secretariat function of a Medical Device Management Group and update the mini-HTA process. The…

NZa (The Dutch Health Authority) recently announced that it will be possible to submit applications for change of the DBC system (Dutch DRG system) until the 1st of June 2017. The DBC system update for 2019 will be…

The Dutch Health Authority (NZa) has compiled all of the healthcare policies that will be applicable during 2018. The policies for specialized care were announced in May, the rest of the sectors in July. The policies…

This seminar will provide out overview of the challenges and limitations, but also the opportunities associated with the analysis of observational data and registry cohorts, particularly with regards to the study of…

The final project plan looking into the use of robotic surgery in thoracic and visceral indications has been released. This rapid assessment will address whether robot-assisted surgery in patients with an indication for…

Our CEO, Mattias Kyhlstedt will be a speaker at The 4th Nordic RWE Conference 2020.

Nathanson, David, Katarina Eeg-Olofsson, Tim Spelman, Erik Bülow, Mattias Kyhlstedt, Fleur Levrat-Guillen, and Jan Bolinder. “Intermittently Scanned Continuous Glucose Monitoring Compared with Blood Glucose Monitoring…

Outcomes of HTA reports vary substantially between different areas of technologies Below is a summary of the outcomes from HTA evaluation regarding different areas of technologies. The scope is European HTAs for medical…

Overview: Discussion around the established and evolving NHS datasets being utilised to generate Real World Evidence to support outcomes research. The webinar will also focus on a selection of disease-specific datasets…

In this webinar, we will introduce and discuss the critical aspects characterizing the highly regionalized Italian healthcare system, with focus on new Essential Levels of Care and on the mixed financing mechanisms…

Mathematical modelling of oncological treatments is a dynamic field in which methods are constantly adjusted to correspond to the features of novel therapies. The biggest uncertainty in health economic modelling of such…

Following Part 1 of the webinar, we will present some of tackled methodological issues through practical examples of cost-effectiveness modelling done and/or published by Mihajlović Health Analytics (MiHA). This will…

There can be huge benefits to developing and implementing digital real-world evidence (RWE) studies with patients, advocates and clinicians. But how do you get them on board, and manage their different needs and…

Most Economically Advantageous Tendering (MEAT) is a procurement tool that focuses on the assessment of quality, life-cycle, costing, cost-effectiveness, and societal benefits. The MEAT Value Based Procurement…

Synergus RWE is committed to protecting data and ensuring the privacy of all our clients and contacts. We have updated our privacy policy to comply with EU’s General Data Protection Regulation, valid from 25 May 2018.…

The ability to potentially use real world data (RWD) for medical devices is a hot topic in the medical device world. In this half day seminar, we will unlock the possibilities and the limitations in the use of RWE for…

Real World Data – Unlocking the potential for medical device companies The ability to potentially use real world data (RWD) for medical devices is a hot topic in the medical device world. In this half day seminar, we…

Evidence For Decisions The foundation for our services is to support our clients in developing evidence for decision-making. We are at the forefront of understanding how Real-World Evidence can be used to support…

In the last few years the German market has been gradually reshaped from having relatively easy access for new innovative medical devices, to increasingly clear requirements for evidence. A recent court case involving…

A few weeks ago, I got in contact with a group of 12 Medical Doctors (associate professors/professors) who had to flee their country. They arrived in Sweden 4 months ago and have initiated the process to be certified…

Digital Health Market Acccess - Reimbursement Application and Hands-On Support The process to establish reimbursement or payment for your solution will vary significantly from country to country. In some countries there…

Number of countries in the reimbursement process require submission of reimbursement/health technology assessment (HTA) dossier for medical technology by manufacturer. In some countries, it is a direct process of…

Reimbursement analysis is essential to understand openness and attractiveness of the market for your technology. Incorrect understanding of reimbursement landscape for technology can postpone market access for years.…

To request the deletion of your personal data, fill in the form below, you will receive an email when your data has been removed from the

The Nordics are known to provide exceptional opportunities for Real-World-Evidence studies due to the rich data. The countries however have rather different availability of data. In this webinar we will have an…

Seminar / webinar: 101 introduction to reimbursement / funding for e-health and diagnostic companies This webinar gives a basic understanding of the elements relating reimbursement/funding for new innovations in…

Many medical device manufacturers have found themselves caught in a trap where they have received NUB status 1 and/or 4 but the hospitals were rejected during the negotiation with the insurance companies. Through our…

The Federal Joint Committee (G-BA) amended the regulations according to which opioid addicts can receive substitution-based therapy at the expense of statutory health insurance (SHI). The current range of services was…

The modifications for breast examination reimbursement, including mammography, will not be applicable from April 1 2018 and a new date has not been set yet. The date of entry into force of the three royal decrees that…

On the 22nd of March the Swiss Federal Office of Public Health (BAG/OFSP) published the updated version of the TARMED tariff system for out-patient services. TARMED 1.09 will be in use from January the 1st 2018. Tariff…

SwissDRG recently announced that it will be possible to submit applications for change of the DRG system from the 29th of April until the 10th of July 2017. Applications can be submitted by stakeholders of the Swiss DRG…

Our CEO Mattias Kyhlstedt has published an editorial in collaboration with Sarah Wamala Andersson about Real World Evidence, “ Deriving more value from RWE to ensure timely access of medicines by patients ”, in the…

We are looking for Dutch-speaking Market Access Analyst or Consultant to join our team to cover market access in the Netherlands. Read more here

We are happy to announce that we are moving offices. We continue to have an office with a beautiful view of the sea, but somewhat closer to the city. We will be in the new office from September 26th. First opportunity…

Our team has recently published the first comprehensive overview of the use of blood glucose monitoring in phase III clinical studies of insulin analogs, “ Systematic literature review of use of blood glucose monitoring…

Our team has published the first comprehensive review of risk prediction models for diabetes after bariatric surgery, " Systematic review of risk prediction models for diabetes after bariatric surgery ," in one of the…

Combining the strategic services with the best in local execution The Athagoras group has acquired a majority stake in Synergus RWE to create the leading market access consultancy offer for medical devices and digital…

We are happy to announce that Mikael Svensson will join us on part-time to strengthen our health economic expertize. Mikael Svensson (PhD, Economics) is a Professor of Applied Health Economics at the University of…

We are happy to announce that experienced statistician and researcher, Olga Rebrova, PhD, Professor, has joined Synergus Evidence Synthesis and Value Development team in September 2016. Olga will be primarily involved…

Our presentation will be about: Choosing RWD from the right league changes everything!? What are the different leagues of Real World Data and how does this change the opportunities for related research? Registry Based…

We are starting a project is to evaluate the existing knowledge on real word evidence based on patient registries through literature review. The first project will be about heart failure. We are currently evaluating…

We are starting a project is to evaluate the existing knowledge on real word evidence based on patient registries through literature review. The second project will be about heart valve surgery. We are currently…

In a document released by BIVDA, it aims to set out what recent developments, such as agreement on the terms of an implementation period for Brexit would mean for the life sciences sector, once finalised as part of the…

The Joint Federal Committee (G-BA) initiated the consultation of test guidelines for six further examination and treatment methods. Medical device manufacturers have submitted corresponding trial applications for these…

When belonging to the EU, organisations carrying out clinical trials in member states, must follow specific regulations and guidelines in order to ensure safety and regularity among trials. Once the UK leaves the EU,…

In this webinar we will provide an update based on the draft legisliation that has been published. Please let us know if you have any specific questions you would like us to address. With the new legislation for…

Using the MSBase registry, this seminar will describe an example of a clinician-initiated project that translated a series of clinical observations into practical, validated nomogram-based tools for the early prediction…

The ability to use AI and different digital solutions to help guiding the patient journey appears very attractive. A study where patients were triaged by a nurse or a doctor demonstrated a significant increase in number…

Traditional way to demonstrate value of technology to customers is through different types of marketing materials (brochures, papers etc.). However, typically limited in size marketing materials fail to fully present…

Click on the links below to open the relevant videos: "Benefit assessment” by G-BA for high class risk devices being reviewed for innovation funding (NUB) in Germany Start of controlled introduction framework for…

Networks analysis has evolved beyond its earlier applications in social research to become a powerful tool for exploring patterns in complex, highly correlate data. This webinar provides a broad introduction to networks…

E-health is a hot topic anticipated to transform healthcare. The mechanisms to fund and pay for e-health solutions are in many countries not as developed as the traditional pathways for drugs, medical devices and…

In this webinar we will provide an introduction to the NUB funding and overview of how the new benefit assessment will provide impact on the innovation funding process. The new benefit assessment by G-BA and IQWiG will…

Webinar: In this webinar we will receive an introduction to the “Model for ASsessment of Telemedicine applications (MAST), developed based on the EUnetHTA model to address the important questions of how to assess…

Year of 2016 brought a lot of changes to reimbursement landscape in Europe. Synergus, leading Med Tech consulting company in Europe, is organizing a free Webinar to share our perspective on the most important changes in…

Previous webinars about digital health: Introduction to funding and reimbursement for E-health / disease management tools (recording) Funding and reimbursement of E-health in…

We now have our recent webinars available to see at your convenience: Observational data – challenges and opportunities and introduction to…

Click here to read more about our services in E-health market access . We expect that E-health solutions will disrupt the future health care. However, the ability to introduce the new innovations are many times limited…

Following the first ever two-year tariff for 2017/18 and 2018/19, NHS England and NHS Improvement had been expected to release their proposals for the next two years. The transition to a two-year tariff appears to have…